0000899243-20-018146.txt : 20200701 0000899243-20-018146.hdr.sgml : 20200701 20200701171503 ACCESSION NUMBER: 0000899243-20-018146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200701 DATE AS OF CHANGE: 20200701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Misfeldt Dayton CENTRAL INDEX KEY: 0001461466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 201006054 MAIL ADDRESS: STREET 1: C/O BAY CITY CAPITAL LLC STREET 2: 750 BATTERY STREET, SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-30 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001461466 Misfeldt Dayton SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, STE. 400 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 See Remarks Stock Option (Right to Buy) 0.2634 2020-06-30 4 A 0 60000 0.00 A 2030-06-30 Common Stock 60000 60000 D The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. Interim Chief Executive Officer (Principal Executive and Principal Financial Officer). /s/Dayton Misfeldt 2020-07-01